| Pramipexole in Out-patients With Idiopathic Restless Legs Syndrome (IRLS) (NCT00654498) | Boehringer Ingelheim | 2008-04-01 |
| Safety, Tolerability, and Pharmacokinetics of BI 201335 NA in Healthy Male Subjects (NCT02182297) | Boehringer Ingelheim | 2008-04-01 |
| Study to Investigate the Effect of Ketoconazole Mediated CYP3A4 Inhibition on Pharmacokinetics of Tamsulosin in Healthy Male Volunteers (NCT02264171) | Boehringer Ingelheim | 2008-04-01 |
| Japanese P III vs Voglibose and Placebo (NCT00654381) | Boehringer Ingelheim | 2008-04-01 |
| Pharmacokinetic Properties of Two Dosages Nevirapine Extended Release (XR) Formulations Compared to VIRAMUNE® Tablet as Well as to Nevirapine XR Tablet in Healthy Male Volunteers (NCT02184312) | Boehringer Ingelheim | 2008-04-01 |
| RE-DEEM Dose Finding Study for Dabigatran Etexilate in Patients With Acute Coronary Syndrome (NCT00621855) | Boehringer Ingelheim | 2008-03-01 |
| STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction (NCT00623623) | Boehringer Ingelheim | 2008-03-01 |
| Safety, Tolerability and Pharmacokinetics of BI 34021 FU2 Oral Drinking Solution in Healthy Male Volunteers (NCT02259842) | Boehringer Ingelheim | 2008-03-01 |
| 26-week Open Study of telmisartan40mg+amlodipine10mg or telmisartan80mg+amlodipine10 mg in Hypertension (NCT00624052) | Boehringer Ingelheim | 2008-03-01 |
| Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone (NCT00641043) | Boehringer Ingelheim | 2008-03-01 |
| Dabigatran Etexilate Compared With Enoxaparin in Prevention of Venous Thromboembolism (VTE) Following Total Hip Arthroplasty (NCT00657150) | Boehringer Ingelheim | 2008-03-01 |
| Pharmacokinetics and Pharmacodynamics of Multiple 5 mg Doses of BI 1356 p.o. Given Once Daily Compared to Multiple 2.5 mg Doses Given Twice Daily in Healthy Male and Female Volunteers (NCT02173652) | Boehringer Ingelheim | 2008-03-01 |
| Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 Diabetes (NCT00622284) | Boehringer Ingelheim | 2008-02-01 |
| Kinetic Tremor in Parkinsons Disease: Its Course Under Pramipexole (Mirapexin®) Treatment and Impact on Quality of Life (NCT01100073) | Boehringer Ingelheim | 2008-02-01 |
| BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes (NCT00602472) | Boehringer Ingelheim | 2008-02-01 |
| Efficacy and Safety of BI 1356 (Linagliptin) Versus Placebo in Type 2 Diabetic Patients With Insufficient Glycemic Control (NCT00621140) | Boehringer Ingelheim | 2008-02-01 |
| Pharmacokinetics of Bisacodyl or Sodium Picosulfate Administered Orally in Healthy Lactating Females (NCT02211911) | Boehringer Ingelheim | 2008-02-01 |
| Effects of BI 44370 TA Orally Applied as Tablets on the Pharmacokinetics of Orally Administered Midazolam Solution in Healthy Volunteers (NCT02217514) | Boehringer Ingelheim | 2008-02-01 |
| Observational Study in Parkinson's Disease of the Primary Care Population of Patients Treated With Pramipexole (NCT02236728) | Boehringer Ingelheim | 2008-02-01 |
| Investigation of the Metabolism and Pharmacokinetics of [14C]BI 1744 CL and [14C]BI 1744 CL Administered as an Oral Solution in Healthy Male Subjects (NCT02172157) | Boehringer Ingelheim | 2008-02-01 |
| Effect of BI 1356 as Single Dose on the QT Interval in Healthy Female and Male Subjects (NCT02183467) | Boehringer Ingelheim | 2008-01-01 |
| Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria (NCT00558467) | Boehringer Ingelheim | 2008-01-01 |
| 4 Week Treatment With Three Oral Doses of BI 10773 in Patients With Type 2 Diabetes (NCT00558571) | Boehringer Ingelheim | 2008-01-01 |
| Open Label Study Telmisartan and Amlodipine in Hypertension (NCT00614380) | Boehringer Ingelheim | 2008-01-01 |
| Bioavailability and Pharmacokinetics of BI 10773 Tablet in Healthy Male Volunteers (NCT02172209) | Boehringer Ingelheim | 2008-01-01 |
| Study to Evaluate the Efficacy and Safety of Tamsulosin in Children With Neurogenic Bladder (NCT00796614) | Boehringer Ingelheim | 2008-01-01 |
| An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination (NCT00618774) | Boehringer Ingelheim | 2008-01-01 |
| Efficacy and Safety of B I1356 (Linagliptin) vs. Placebo Added to Metformin Background Therapy in Patients With Type 2 Diabetes (NCT00601250) | Boehringer Ingelheim | 2008-01-01 |
| Bioavailability of BI 44370 TA Drinking Solution or Tablets With and Without a High Fat Meal in Healthy Male and Female Volunteers (NCT02215746) | Boehringer Ingelheim | 2008-01-01 |
| Tiotropium Once Daily 18 Mcg Versus Salmeterol Twice Daily 50 Mcg on Time to First Exacerbation in COPD Patients. (NCT00563381) | Boehringer Ingelheim | 2008-01-01 |
| Long-term Safety Study of Open-label Pramipexole Extended Release (ER) in Patients With Early Parkinson´s Disease (PD). (NCT00601523) | Boehringer Ingelheim | 2008-01-01 |
| Bioavailability of Soft Gelatin Capsule Formulation of BI 201335 NA Compared to the Solution Formulation in Healthy Volunteers (NCT02182284) | Boehringer Ingelheim | 2008-01-01 |
| Multiple Rising Inhalative Doses of BI 1744 CL in Healthy Male Volunteers (NCT02172105) | Boehringer Ingelheim | 2008-01-01 |
| Safety, Tolerability and Pharmacokinetics of Single Rising Inhaled Doses of BI 11054 CL Administered With the Respimat® in Healthy Male Volunteers (NCT02273401) | Boehringer Ingelheim | 2008-01-01 |
| Safety and Effectiveness of Spiriva in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual Practice (NCT00624377) | Boehringer Ingelheim | 2007-12-01 |
| Long-term Safety Study of Open-label Pramipexole ER in Patients With Advanced PD (NCT00577460) | Boehringer Ingelheim | 2007-12-01 |
| Multiple Oral Doses of BI 207127 NA in Treatment naïve and Treatment-experienced Hepatitis C Virus (HCV)-Infected Patients (NCT02176525) | Boehringer Ingelheim | 2007-12-01 |
| Safety and Effect of Mirapex(Pramipexole) Tablet Among Korean RLS (NCT01170091) | Boehringer Ingelheim | 2007-12-01 |
| A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period (NCT00560508) | Boehringer Ingelheim | 2007-11-01 |
| VERxVE Study on Efficacy and Safety of Nevirapine XR in Comparison to Nevirapine IR With Truvada in Naive HIV+ Patients (NCT00561925) | Boehringer Ingelheim | 2007-11-01 |
| Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE (NCT00558259) | Boehringer Ingelheim | 2007-11-01 |
| Relative Bioavailability of Dabigatran Etexilate Capsules With and Without Quinidine Sulfate Tablets and to Measure the Effect of Quinidine on the Absorption of Fexofenadine in Healthy Male and Female Volunteers (NCT02171546) | Boehringer Ingelheim | 2007-11-01 |
| Cross-Sectional Study: Prevalence of Restless Legs Syndrome in Patients With Unpleasant Sensations of the Legs (NCT00557258) | Boehringer Ingelheim | 2007-11-01 |
| Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension (NCT00553267) | Boehringer Ingelheim | 2007-11-01 |
| Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension (NCT00558428) | Boehringer Ingelheim | 2007-10-01 |
| Relative Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers (NCT02259803) | Boehringer Ingelheim | 2007-10-01 |
| Sodium Picosulphate vs. Placebo in Functional Constipation (NCT00576810) | Boehringer Ingelheim | 2007-10-01 |
| Filtered Trial for Telmisartan 40mg Non-responder (NCT00550953) | Boehringer Ingelheim | 2007-10-01 |
| Tipranavir/Ritonavir Low Dose Pharmacokinetics in Treatment Naive Patients (NCT00530920) | Boehringer Ingelheim | 2007-10-01 |
| Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease (NCT00558025) | Boehringer Ingelheim | 2007-10-01 |
| Bioavailability of Four Oral Prototype Extended Release Formulations With BI 11634 in Healthy Male Volunteers (NCT02214953) | Boehringer Ingelheim | 2007-10-01 |
| Filtered Trial for Amlodipine Non-responder (NCT00558064) | Boehringer Ingelheim | 2007-10-01 |
| Influence of Food on the Bioavailability of Telmisartan / Ramipril Fixed Dose Combination in Healthy Male and Female Volunteers (NCT02214966) | Boehringer Ingelheim | 2007-10-01 |
| Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium in COPD (NCT00535366) | Boehringer Ingelheim | 2007-10-01 |
| An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler. (NCT00528996) | Boehringer Ingelheim | 2007-09-06 |
| Bioavailability of Telmisartan/Amlodipine Fixed Dose Combination in Healthy Male and Female Volunteers (NCT02259777) | Boehringer Ingelheim | 2007-09-01 |
| Sifrol (Pramipexole) Onset of Action and Impact: a 12-weeks Observational Study in Patients With Primary Restless Legs Syndrome (NCT00721279) | Boehringer Ingelheim | 2007-09-01 |
| Bioequivalence Study of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers (NCT02259829) | Boehringer Ingelheim | 2007-09-01 |
| Dulcolax vs Placebo in Functional Constipation (NCT00526097) | Boehringer Ingelheim | 2007-09-01 |
| An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice (NCT00982735) | Boehringer Ingelheim | 2007-09-01 |
| Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced (NCT00793793) | Boehringer Ingelheim | 2007-09-01 |
| Effect of Tiotropium Plus Salmeterol vs. Fluticasone/Salmeterol on Static Lung Volumes and Exercise Endurance in COPD (NCT00530842) | Boehringer Ingelheim | 2007-09-01 |
| Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT) (NCT00552240) | Boehringer Ingelheim | 2007-09-01 |
| Comparison of TPV/r to DRV/r in Triple Class Experienced Patient With Resistance to > 1 PI (NCT00517192) | Boehringer Ingelheim | 2007-09-01 |
| Bioequivalence of Telmisartan/Amlodipine Fixed Dose Combination Compared With Its Monocomponents in Healthy Male and Female Volunteers (NCT02193308) | Boehringer Ingelheim | 2007-09-01 |
| Safety And Efficacy of BIBF 1120 in Idiopathic Pulmonary Fibrosis (NCT00514683) | Boehringer Ingelheim | 2007-08-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 44847 Administered to Healthy Male Subjects (NCT02211924) | Boehringer Ingelheim | 2007-08-01 |
| BIBW 2992 (Afatinib) in Head & Neck Cancer (NCT00514943) | Boehringer Ingelheim | 2007-08-01 |
| Tiotropium In Exercise (NCT00525512) | Boehringer Ingelheim | 2007-08-01 |
| LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations (NCT00525148) | Boehringer Ingelheim | 2007-08-01 |
| Effects of Steady State Tipranavir/Ritonavir or Darunavir/Ritonavir or Ritonavir on Platelet Function, Coagulation and Fibrinolysis Biomarkers in Healthy Subjects (NCT02251795) | Boehringer Ingelheim | 2007-08-01 |
| Double-blind Trial to Investigate Efficacy and Tolerance of Ambroxol Lozenges 20 mg in Sore Throat (NCT00525044) | Boehringer Ingelheim | 2007-08-01 |
| Bioavailability of Telmisartan/Amlodipine Fixed-dose Combination Compared to Its Mono-components in Healthy Male Volunteers (NCT02259790) | Boehringer Ingelheim | 2007-07-01 |
| EARLY 3-months Aggrenox Treatment Started Within 24 Hrs of Ischemic Stroke Onset vs. After One Week 100 mg ASA (NCT00562588) | Boehringer Ingelheim | 2007-07-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 Tablets (NCT01924767) | Boehringer Ingelheim | 2007-07-01 |
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple, Rising Oral Doses of BI 11634 Oral Solution in Healthy Male Volunteers (NCT02214940) | Boehringer Ingelheim | 2007-06-01 |
| Clinical EvaluatioN of TElmisartan-based Antihypertensive Regimen (NCT00613314) | Boehringer Ingelheim | 2007-06-01 |
| 4 Weeks Treatment of Type II Diabetic Patients With BI 44847 (NCT00558909) | Boehringer Ingelheim | 2007-06-01 |
| Dose-finding Study of BI 2536 Administered in Combination With Gemcitabine in Patients With Locally Advanced or Metastatic Pancreatic Cancer (NCT02215044) | Boehringer Ingelheim | 2007-06-01 |
| BI 811283 in Various Solid Tumours (NCT00701324) | Boehringer Ingelheim | 2007-06-01 |
| Via Respimat® Inhaled BI 1744 CL Compared to Moxifloxacin and Placebo in Healthy Male and Female Volunteers (NCT02172144) | Boehringer Ingelheim | 2007-06-01 |
| Pharmaco-epidemiological Description of the Population Treated With Aptivus Under Market Conditions, Safety & Efficacy (NCT00615290) | Boehringer Ingelheim | 2007-06-01 |
| Single Rising Peroral Doses of BI 1744 CL in Healthy Volunteers (NCT02171793) | Boehringer Ingelheim | 2007-06-01 |
| Italian Prospective Data Collection for Better Patient Characterization in a Highly Treatment Experienced Population (NCT00614302) | Boehringer Ingelheim | 2007-06-01 |
| Steady State Pharmacokinetics of Telmisartan, Ramipril or the Combination Following Repeated Oral Doses to Healthy Male and Female Volunteers (NCT02215005) | Boehringer Ingelheim | 2007-06-01 |
| Pharmacokinetics and Relative Bioavailability of 11634 Immediate Release Tablet in Healthy Male Volunteers (NCT02214927) | Boehringer Ingelheim | 2007-05-01 |
| Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of BI 201335 NA in Healthy Male Subjects (NCT02182362) | Boehringer Ingelheim | 2007-05-01 |
| Trial Exploring Afatinib (BIBW 2992) + Paclitaxel (Part A), Afatinib + Paclitaxel + Bevacizumab (Part B), Afatinib + Carboplatin (Part C) and Afatinib+ Paclitaxel +Carboplatin(Part D) in Patients With Advanced Solid Tumours (NCT00809133) | Boehringer Ingelheim | 2007-05-01 |
| Pharmacokinetics, Safety and Tolerability of Rising Doses of Buscopan® in Healthy Male Volunteers (NCT02261077) | Boehringer Ingelheim | 2007-05-01 |
| Efficacy and Safety of 4 Weeks of Treatment With Inhaled BI 1744 CL in Patients With Asthma (NCT00467740) | Boehringer Ingelheim | 2007-05-01 |
| Influence of Pramipexole on the QT Interval of the ECG in Healthy Male and Female Volunteers (NCT02262546) | Boehringer Ingelheim | 2007-05-01 |
| Efficacy, Safety, Tolerability of Pramipexol ER Versus Pramipexol IR Versus Placebo in Early PD Patients (NCT00479401) | Boehringer Ingelheim | 2007-05-01 |
| Long-term Efficacy, Safety and Tolerability of Pramipexole in Patients With Idiopathic Moderate to Severe Restless Legs Syndrome (RLS) (NCT00472199) | Boehringer Ingelheim | 2007-05-01 |
| Observational Non-interventional Study With Spiriva in Chronic Obstructive Pulmonary Disease Patients With Exercise-induced Dyspnoea (NCT00540163) | Boehringer Ingelheim | 2007-04-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Inhalative Doses of BI 1744 CL in Fixed Dose Combination With Tiotropium Bromide in Healthy Male Volunteers (NCT02259959) | Boehringer Ingelheim | 2007-04-01 |
| Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD). (NCT00523991) | Boehringer Ingelheim | 2007-04-01 |
| Safety, Tolerability and Pharmacokinetics of BI 44370 TA Oral Drinking Solution in Healthy Male Volunteers (NCT02215018) | Boehringer Ingelheim | 2007-04-01 |
| Pivotal Study in Advanced Parkinsons Disease Patients (NCT00466167) | Boehringer Ingelheim | 2007-04-01 |
| Effect of Spiriva on the Activities of Daily Living Score Recommended in Austrian COPD Guidelines (NCT00615992) | Boehringer Ingelheim | 2007-04-01 |
| Utilization of HIV Drug Resistance Testing in Treatment Experienced Patients (UTILIZE Study) (NCT00615563) | Boehringer Ingelheim | 2007-03-01 |